Science of Drugs

The Michigan marijuana initiative still has a healthy lead as Election Day nears, the FDA has granted "breakthrough therapy" status for psilocybin for treatment-resistant depression, and more.

These powerful substances are making their way into the heart of the psychology establishment and starting to be understood as powerful therapeutic tools.

Some groundbreaking research begins to look for answers.

A clinical trial underway right now hopes to find the answer -- and more participants.

This helps explain why they are increasingly seen as a valuable treatment for psychiatric disorders such as depression, anxiety, and addiction.

FDA-approved research on MDMA and PTSD gets a big monetary bump courtesy of Dr. Bronner's, Human Right Watch condemns the failure to make the opioid overdose reversal drug naloxone more available, a safe injection site bill is moving in California, and more.

The National Academy of Sciences releases a report finding marijuana is medicine, Rhode Island legislators aim to get pot legal in a hurry, a new bill in Washington state would allow home cultivation, and more.

Some former NFL players would rather treat their aches and pains with medical marijuana than opiates, an effort to put medical marijuana on the ballot in Oklahoma comes up short, Bolivia's president vows to fight for coca decriminalization, and more.

For the first time, legislation has been introduced that would end the federal prohibition on medical marijuana.

Marijuana arrests are up in a third of the states, the drug czar's office responds to the New York Times, Dr. Carl Hart wins a literary award, Philly narcs get busted, and more.